The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Gilead Sciences; Ipsen; Janssen; Merck; MSD; Novartis; RIEMSER
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Cellox; ClinSol; Hexal; iOMEDICO; MSD; Novartis; RIEMSER; Roche; Tesaro; Teva
 
Honoraria - Amgen; Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Falk Foundation; Falk Foundation; Lilly; Lilly; MCI Group; MCI Group; Merck Serono; Merck Serono; MSD; MSD; Nordic Bioscience; Nordic Bioscience; Pfizer; Pfizer; Roche; Roche
Consulting or Advisory Role - Amgen; Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Falk Foundation; Falk Foundation; Lilly; Lilly; MCI Group; MCI Group; Merck Serono; Merck Serono; MSD; MSD; Nordic Bioscience; Nordic Bioscience; Pfizer; Pfizer; Roche; Roche
Research Funding - Amgen (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Merck Serono (Inst); Merck Serono (Inst); MSD (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; Merck Serono; MSD; MSD; Roche; Roche
Survival after secondary liver resection in metastatic colorectal cancer: A comparative analysis of the LICC trial with historical controls (CELIM, FIRE-3).
 
Markus Hermann Moehler
No Relationships to Disclose
 
Gunnar Folprecht
Honoraria - Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Mundipharma; Roche/Genentech; Sanofi/Aventis; SERVIER
Research Funding - Merck KGaA
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical
 
Julian Holch
Honoraria - Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Annett Maderer
Patents, Royalties, Other Intellectual Property - J.-G. University Mainz
 
Stefan Kasper
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Roche; Shire; Shire
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Merck Serono; Roche; Sanofi
Other Relationship - Amgen; Merck Serono; Sanofi
 
Susanna Hegewisch-Becker
No Relationships to Disclose
 
Jan Schroeder
No Relationships to Disclose
 
Friedrich Overkamp
No Relationships to Disclose
 
Frank Kullmann
No Relationships to Disclose
 
Wolf Otto Bechstein
Honoraria - Astellas Pharma; Baxter; Integra LifeSciences; MCI Group; Medupdate; Merck Serono; Teva
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Integra LifeSciences
 
Matthias Voehringer
Consulting or Advisory Role - Roche
 
Robert Oellinger
No Relationships to Disclose
 
Florian Lordick
Honoraria - AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Infomedica; Lilly; Merck KGaA; Merck Sharp & Dohme; Roche; SERVIER
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; SERVIER
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
Michael Geissler
No Relationships to Disclose
 
Armin Schulz-Abelius
No Relationships to Disclose
 
Bernhard Linz
No Relationships to Disclose
 
Helga Bernhard
No Relationships to Disclose
 
Irene Schmidtmann
Research Funding - Merck Serono (Inst)
 
Carl Christoph Schimanski
Employment - Merck KGaA (I)
Research Funding - Merck KGaA (Inst)